Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019.

This research reveals marked BPH burden differences between China and the US (1990-2019). China's higher burden necessitates targeted interventions, while unique trends in both countries demand tailored strategies. These insights enhance understanding of BPH dynamics, informing effective interventions across diverse contexts.